Sr. Director-Global Regulatory Affairs-North America
Company: Eli Lilly Company
Location: Indianapolis
Posted on: May 27, 2023
Job Description:
At Lilly, we unite caring with discovery to make life better for
people around the world. We are a global healthcare leader
headquartered in Indianapolis, Indiana. Our 35,000 employees around
the world work to discover and bring life-changing medicines to
those who need them, improve the understanding and management of
disease, and give back to our communities through philanthropy and
volunteerism. We give our best effort to our work, and we put
people first. We're looking for people who are determined to make
life better for people around the world.
Sr. Director, GRA-NA Regulatory Scientist
Organization Overview:
At Lilly, we serve an extraordinary purpose. For more than 140
years, we have worked tirelessly to discover medicines that make
life better. These discoveries start in Lilly Research
Laboratories, where our scientists work to create new medicines
that will help solve our world's greatest health challenges.
Purpose:
The purpose of the Sr. Director, Regulatory Scientist role is to
provides leadership and oversight to deliver US and Canada
regulatory strategies and win through regulatory for assigned
assets.The Regulatory Scientist partners across Lilly teams,
partner companies, and health authorities to enable market
differentiation of first-in-class/best-in-class assets.
Primary Responsibilities: This job description is intended to
provide a general overview of the job requirements at the time it
was prepared. The job requirements of any position may change over
time and may include additional responsibilities not specifically
described in the job description. Consult with your supervision
regarding your actual job responsibilities and any related duties
that may be required for the position.
Responsibilities:
Develop, Update and Execute US and Canada Registration Strategy
Initiate and Update Regulatory Strategy Document
- Initiate and update regulatory strategy documents by leveraging
scientific, drug/device clinical development and knowledge from
FDA/HC meetings and regulatory trends. Integrate information from
the external environment, product specific regulator advice, and
other public information (i.e. Advisory Committees) to develop
robust, innovative regulatory strategies.
- Review, summarize, and present information regarding regulator
expectations by utilizing agency feedback received by Lilly and
knowledge of competitor labelling.
- Monitor upcoming and recent approvals of competitive
development programs/plans
- Integrate US/CA regulatory strategy into global registration
strategy
- Serve as global regulatory coordinator as assigned by GRA
management.
- Partner with colleagues across regulatory functions to deliver
integrated US/Canada regulatory strategy
- Communicate and share key information to enable seamless
execution of US/Canada regulatory strategy
Provide input to clinical program to support market differentiation
needs
- Communicate the regulatory options and impact on proposed
product development plans.
- Leverage innovative regulatory strategies with accompanying
required data to accelerate asset development while enabling market
differentiation of first-in-class/best-in-class assets.
- Collaborate with PRA and GPO-RWE for the success of the pricing
and access strategies through influencing what data is needed and
how it is collected on development or product lifecycle
planning
Lead development and update of labeling strategy to deliver market
differentiation
Initiate and update Target Product Profile, Claims Mapping, and
Labeling Dashboard
- Partner with regulatory, product and clinical development,
commercial and project personnel to drive a Market Differentiation
as Driver Strategy using available tools and resources (e.g., TPP,
Claims mapping) and network for alignment.Confirm, challenge,
influence, and communicate strategic discussions based on industry
precedent and new developments.Use global labelling strategy to
influence the drug development strategy, as needed.
- Create and communicate labeling dashboard to drive internal
alignment on labeling strategy and key risks.
Develop and Update US and CA labeling, including prescribing
information, patient labeling, device labeling (IFU) for new
products and indications
- Lead the development of the US/Canadian labelling strategy in
collaboration with other regulatory and project personnel and
network for alignment across affiliate labelling team to enable
timely completion of US/Canadian product (drug and device)
registration milestones (submission, approval and launch).
- Lead strategic development of US/CA labelling documents for
initial submission, line extensions, key MOH-initiated changes, and
key PMR-related updates, and provide responses to agency labelling
questions. Apply labelling expertise, competitor knowledge, and
regulatory precedent to propose labelling content to influence
commercially viable labelling.
Lead and develop the strategy for submission and amendments for:
IND, IDE, NDA/BLA, NDS, PMA/510(k), and de novo
- Determine and communicate submission and approval requirements
and regulator expectations
- Generate regulatory documents for medium to high complexity
submissions.Ensure the regulatory documents contain appropriate
data/information based on regulator expectations and are clearly
written to articulate Lilly's scientific position.
- Anticipate, resolve, and communicate key technical,
operational, and strategic issues that may impact the MDU function
or the development team.
- Propose innovative solutions to regulatory and labelling issues
to meet the business objectives while maintaining compliance with
applicable regulations and internal quality systems.
Primary liaison with product and clinical development team and
liaison with diagnostic development experts
- Provide high quality, timely and decisive regulatory advice
that enables business partners to make well-informed decisions on
development of drugs, diagnostics, devices, and product lifecycle
planning and business development
- Communicate regulatory risks, potential impact and mitigation
plans with development team leadership and regulatory
management
- Cultivate relationships with development teams and
leadership.
Liaison with global marketing/NPP/HO/GPORWE/Payer functions/US
Brand Teams
- Contribute to global and US launch-readiness plan and connect
commercial partners (global marketing/NPP/GPORWE/Payer functions/US
Brand Teams) with development teams to drive market differentiation
strategy for assigned assets, including labelling and promotional
deliverables throughout the product lifecycle
- Cultivate relationships with global
marketing/NPP/HO/GPORWE/Payer functions/US Brand Teams and
US/Canadian affiliate leadership.
Own relationship and interaction strategy with US and Canada
regulatory authorities
- Build, maintain, and leverage relationships with FDA, Health
Canada, team members, and partner companies as appropriate.
- Execute high quality communications with FDA, Health Canada and
internal customers to articulate and ensure understanding of the
regulatory strategy and complex issues.
- Accountable for communications to the regulator, development
teams, and GRA, MDU, Research, and BU leadership.
Engage in, influence, and shape external environment initiatives
related to portfolio assets
- Creates and fosters strategic relationship with key external
players to identify and anticipate opportunities for growth.This
may include FDA, external regulatory experts, academic thought
leaders, and industry groups.
Advise/Approve US promotional strategy and claims
Review corporate communications press releases and social media
posts
- Set appropriate direction with Global Marketing and US Brand
Team for development, review and approval of promotional
claims
- Partner with Regulatory Ad/Promo reviewer to advise US Brand
Team on promotional strategy
- Partner with Regulatory Ad/Promo reviewer to review and approve
press materials and IR communications.
Lead/Influence/Partner
- Exemplify Team Lilly behaviors: Include, Innovate, Accelerate,
Deliver in internal and external interactions
- Model the innovation and leadership behaviors and regulatory
excellence attributes as described in Global Regulatory Affairs
white papers.
- Participate in forums that share regulatory information across
GRA components and other Lilly teams and business partners
- Constructively challenge teams to reach the best solutions to
issues
- Create and lead in an environment that encourages open
discussions on issues to achieve a robust outcome on business
decisions
- Serve as a mentor for GRA-NA personnel and others in GRA
Basic Qualifications:
- Bachelor's degree in a science related field
- Minimum of 5 years industry-related experience in regulatory
affairs and/or drug development
Additional Preferences:
- Advanced scientific degree (i.e., PhD, MD, PharmD) strongly
preferred
- Knowledge of FDA and Health Canada procedures and practices
across Review Divisions and awareness of evolving regulatory reform
initiatives desirable
- Demonstrated deep knowledge of the drug development process,
Lilly regulatory/business strategies and plans required
- Demonstrated ability to assess and manage risk in a highly
regulated environment
- Demonstrated strong written, spoken and presentation
communication
- Demonstrated negotiation and influence skills
- Demonstrated attention to detail
- Demonstrated effective teamwork skills; able to adapt to
diverse interpersonal styles
Additional Information:
- Travel expected (10-15%)
Eli Lilly and Company, Lilly USA, LLC and our wholly owned
subsidiaries (collectively "Lilly") are committed to help
individuals with disabilities to participate in the workforce and
ensure equal opportunity to compete for jobs. If you require an
accommodation to submit a resume for positions at Lilly, please
email Lilly Human Resources (
Lilly_Recruiting_Compliance@lists.lilly.com ) for further
assistance. Please note This email address is intended for use only
to request an accommodation as part of the application process. Any
other correspondence will not receive a response.
Lilly is an EEO/Affirmative Action Employer and does not
discriminate on the basis of age, race, color, religion, gender,
sexual orientation, gender identity, gender expression, national
origin, protected veteran status, disability or any other legally
protected status.
Our employee resource groups (ERGs) offer strong support networks
for their members and help our company develop talented individuals
for future leadership roles. Our current groups include: Africa,
Middle East, Central Asia Network, African American Network,
Chinese Culture Network, Early Career Professionals, Japanese
International Leadership Network (JILN), Lilly India Network,
Organization of Latinos at Lilly, PRIDE (LGBTQ + Allies), Veterans
Leadership Network, Women's Network, Working and Living with
Disabilities. Learn more about all of our groups.
As a condition of employment with Eli Lilly and Company and its
subsidiaries in the United States and Puerto Rico, you must be
fully COVID-19 vaccinated and provide proof of vaccination
satisfactory to the company (subject to applicable law).
#WeAreLilly
Keywords: Eli Lilly Company, Indianapolis , Sr. Director-Global Regulatory Affairs-North America, Executive , Indianapolis, Indiana
Didn't find what you're looking for? Search again!
Loading more jobs...